Citius Pharmaceuticals, Inc. (CTXR)
NASDAQ: CTXR · Real-Time Price · USD
0.5451
-0.0123 (-2.21%)
At close: Nov 6, 2026, 4:00 PM EST
0.5473
+0.0022 (0.40%)
After-hours: Nov 6, 2026, 7:59 PM EST
Citius Pharmaceuticals Employees
Citius Pharmaceuticals had 23 employees as of September 30, 2025. The number of employees did not change compared to the previous year. That makes Citius Pharmaceuticals the 37,955th largest employer in the world and 5,395th in the United States.
Employees
23
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$308,922
Profits / Employee
-$2,011,915
Market Cap
14.96M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Sep 30, 2025 | 23 | 0 | - |
| Sep 30, 2024 | 23 | 1 | 4.55% |
| Sep 30, 2023 | 22 | 1 | 4.76% |
| Sep 30, 2022 | 21 | 6 | 40.00% |
| Sep 30, 2021 | 15 | 5 | 50.00% |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Pluri | 113 |
| Acumen Pharmaceuticals | 61 |
| aTyr Pharma | 60 |
| Kyntra Bio | 34 |
| Bolt Biotherapeutics | 23 |
| Jasper Therapeutics | 22 |
| NewcelX | 12 |
| Allarity Therapeutics | 8 |
CTXR News
- 4 days ago - Citius Oncology's Positive Quality of Life Data for LYMPHIR® (denileukin diftitox-cxdl) in Relapsed or Refractory Cutaneous T-Cell Lymphoma Presented at Premier Global CLTG Congress in Europe - PRNewsWire
- 13 days ago - Citius Oncology Reports Continued Institutional Demand and 120% Growth in Shipments of LYMPHIR® Units to U.S. Wholesalers During the Fiscal Fourth Quarter of 2026 - PRNewsWire
- 27 days ago - Citius Pharmaceuticals to Participate in October 2026 Investor Conferences - PRNewsWire
- 7 weeks ago - Citius Pharmaceuticals Transcript: H.C. Wainwright 28th Annual Global Investment Conference - Transcripts
- 2 months ago - Citius Pharmaceuticals Transcript: Moody Capital Disruptive Growth & Life Science Conference - Transcripts
- 2 months ago - Citius Pharmaceuticals to Participate in September 2026 Investor Conferences - PRNewsWire
- 2 months ago - Citius Pharmaceuticals, Inc. Reports Fiscal Third Quarter 2026 Financial Results and Provides Business Update - PRNewsWire
- 2 months ago - Citius Oncology, Inc. Reports Fiscal Third Quarter 2026 Financial Results and Provides Business Update - PRNewsWire